Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice

[1]  P. Dederen,et al.  Microvascular cerebral blood volume changes in aging APPswe/PS1dE9 AD mouse model: a voxel-wise approach , 2013, Brain Structure and Function.

[2]  J. Wang,et al.  Hypothermia protects against oxygen–glucose deprivation-induced neuronal injury by down-regulating the reverse transport of glutamate by astrocytes as mediated by neurons , 2013, Neuroscience.

[3]  P. Dederen,et al.  Sex Differences in Presynaptic Density and Neurogenesis in Middle-Aged ApoE4 and ApoE Knockout Mice , 2013, Journal of neurodegenerative diseases.

[4]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[5]  F. Battaglia,et al.  n-3 fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell activating factor (BAFF) transgenic mice. , 2012, Preventive medicine.

[6]  C. Holscher,et al.  The effect of ageing on neurogenesis and oxidative stress in the APPswe/PS1deltaE9 mouse model of Alzheimer's disease , 2012, Brain Research.

[7]  P. Kamphuis,et al.  A specific multi‐nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro , 2012, Journal of neurochemistry.

[8]  Guowei Huang,et al.  Folic acid enhances Notch signaling, hippocampal neurogenesis, and cognitive function in a rat model of cerebral ischemia , 2012, Nutritional neuroscience.

[9]  F. Gage,et al.  Adult hippocampal neurogenesis and its role in Alzheimer's disease , 2011, Molecular Neurodegeneration.

[10]  P. Scheltens,et al.  Efficacy of a medical food on cognition in Alzheimer’s Disease: Results from secondary analyses of a randomized, controlled trial , 2011, The journal of nutrition, health & aging.

[11]  R. Agrawal,et al.  Omega-3 Fatty Acid Deficiency during Brain Maturation Reduces Neuronal and Behavioral Plasticity in Adulthood , 2011, PloS one.

[12]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[13]  J. Homberg,et al.  A mixed polyunsaturated fatty acid diet normalizes hippocampal neurogenesis and reduces anxiety in serotonin transporter knockout rats , 2011, Behavioural pharmacology.

[14]  P. Barberger‐Gateau,et al.  Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. , 2011, Current Alzheimer research.

[15]  H. Schipper.  Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment , 2011, Neurobiology of Aging.

[16]  F. Calon,et al.  DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice , 2011, PloS one.

[17]  Henriette van Praag,et al.  When neurogenesis encounters aging and disease , 2010, Trends in Neurosciences.

[18]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[19]  Yadong Huang.  Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases , 2010, Current opinion in lipidology.

[20]  G. Michael,et al.  Omega‐3 fatty acids reverse age‐related decreases in nuclear receptors and increase neurogenesis in old rats , 2010, Journal of neuroscience research.

[21]  O. Lazarov,et al.  Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice , 2010, Journal of neuroscience research.

[22]  P. Myint,et al.  Systematic review on evidence of the effectiveness of cholesterol-lowering drugs , 2010, Advances in therapy.

[23]  Marcus Richards,et al.  Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. , 2010, The American journal of clinical nutrition.

[24]  O. Lazarov,et al.  Neurogenesis and Alzheimer's disease: At the crossroads , 2010, Experimental Neurology.

[25]  G. Cole,et al.  DHA may prevent age-related dementia. , 2010, The Journal of nutrition.

[26]  Ling Wei,et al.  Sublethal Transient Global Ischemia Stimulates Migration of Neuroblasts and Neurogenesis in Mice , 2010, Translational Stroke Research.

[27]  G. Jicha,et al.  Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease , 2010, Clinical interventions in aging.

[28]  P. Scheltens,et al.  Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial , 2010, Alzheimer's & Dementia.

[29]  Yanbo Zhang,et al.  Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model , 2009, Hippocampus.

[30]  H. Feldman,et al.  Therapeutic potential of statins in Alzheimer's disease , 2009, Journal of the Neurological Sciences.

[31]  C. Lavie,et al.  Omega-3 polyunsaturated fatty acids and cardiovascular diseases. , 2009, Journal of the American College of Cardiology.

[32]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[33]  G. Cole,et al.  Omega-3 fatty acids and dementia. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[34]  C. Wellington,et al.  Why lipids are important for Alzheimer disease? , 2009, Molecular and Cellular Biochemistry.

[35]  P. Dederen,et al.  DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice , 2009, Neurobiology of Disease.

[36]  T. A. Carpenter,et al.  Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry , 2009, Neurobiology of Disease.

[37]  C. Kelche,et al.  Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks , 2008, Behavioural Brain Research.

[38]  F. LaFerla,et al.  Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau , 2008, The Journal of Neuroscience.

[39]  D. Abrous,et al.  Retinoic Acid Restores Adult Hippocampal Neurogenesis and Reverses Spatial Memory Deficit in Vitamin A Deprived Rats , 2008, PloS one.

[40]  A Hofman,et al.  Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[41]  B. Shukitt-Hale,et al.  B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice , 2008, Proceedings of the National Academy of Sciences.

[42]  Shih-Yi Huang,et al.  The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  Zhi-jun Zhang,et al.  Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress , 2008, Behavioural Brain Research.

[44]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[45]  J. Palmblad,et al.  Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms , 2008, International journal of geriatric psychiatry.

[46]  T. Peters,et al.  No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial , 2008, British Journal of Nutrition.

[47]  Victoria J. Bourne,et al.  n–3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood , 2008 .

[48]  A. Blokland,et al.  LDL receptor deficiency results in decreased cell proliferation and presynaptic bouton density in the murine hippocampus , 2007, Neuroscience Research.

[49]  T. Kihara,et al.  Decreased proliferation of hippocampal progenitor cells in APPswe/PS1dE9 transgenic mice , 2007, Neuroreport.

[50]  R. Leighty,et al.  A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer’s transgenic mice , 2007, Neuroscience.

[51]  H. Tanila,et al.  Role of α-synuclein in synaptic glutamate release , 2007, Neurobiology of Disease.

[52]  F. Schmitt,et al.  Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.

[53]  Simon T. Bate,et al.  Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease , 2007, Behavioural Brain Research.

[54]  Erik L Ritman,et al.  Vasa vasorum neovascularization and lesion distribution among different vascular beds in ApoE-/-/LDL-/- double knockout mice. , 2007, Atherosclerosis.

[55]  S. Teramukai,et al.  Prevention and Treatment of Dementia or Alzheimer’s Disease by Statins: A Meta-Analysis , 2007, Dementia and Geriatric Cognitive Disorders.

[56]  J. Csernansky,et al.  Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 mice , 2007, The Journal of comparative neurology.

[57]  O. Levi,et al.  Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice , 2007, Journal of neurochemistry.

[58]  O. Shido,et al.  Docosahexaenoic acid promotes neurogenesis in vitro and in vivo , 2006, Neuroscience.

[59]  Heikki Tanila,et al.  Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α‐synuclein knockout and A30P transgenic mice , 2006, Journal of neurochemistry.

[60]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[61]  P. Taupin.  Neurogenesis and Alzheimer’s Disease , 2006, Drug target insights.

[62]  P. Lucassen,et al.  Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus , 2006, Neurobiology of Disease.

[63]  F. Schmitt,et al.  Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment , 2006, Neurobiology of Aging.

[64]  Noriyuki Matsukawa,et al.  Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction , 2006, Neuroscience Research.

[65]  N. Salem,et al.  Omega-3 fatty acids and rodent behavior. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[66]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[67]  I. Skoog,et al.  Update on hypertension and Alzheimer's disease , 2006, Neurological research.

[68]  H. Tanila,et al.  Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice , 2006, Neurobiology of Disease.

[69]  G. Cole,et al.  Docosahexaenoic Acid Protects from Amyloid and Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2006, Nutrition and health.

[70]  J. Savitz,et al.  Apolipoprotein E variants and cognition in healthy individuals: A critical opinion , 2006, Brain Research Reviews.

[71]  A. von Eckardstein,et al.  Brain Cholesterol Synthesis in Mice Is Affected by High Dose of Simvastatin but Not of Pravastatin , 2006, Journal of Pharmacology and Experimental Therapeutics.

[72]  K. Jin,et al.  Neurodegeneration and neurogenesis: focus on Alzheimer's disease. , 2006, Current Alzheimer research.

[73]  Yadong Huang.  Apolipoprotein E and Alzheimer disease , 2006, Neurology.

[74]  L. H. Kuller,et al.  Benefits of fatty fish on dementia risk are stronger for those without APOE ε4 , 2005, Neurology.

[75]  F. Corradeschi,et al.  Cognitive and physiological effects of Omega‐3 polyunsaturated fatty acid supplementation in healthy subjects , 2005, European journal of clinical investigation.

[76]  G. John,et al.  Evidence for growth-promoting effects of Omega n −3 fatty acids alone and in combination with a specific vitamin and mineral complex in rat neuroblastoma cells , 2005, Nutritional neuroscience.

[77]  Hilkka Soininen,et al.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.

[78]  R. Green,et al.  APOE, vascular pathology, and the AD brain , 2005, Neurology.

[79]  H. Steinbusch,et al.  Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. , 2005, The American journal of pathology.

[80]  A. Desai,et al.  Diagnosis and treatment of Alzheimer’s disease , 2005, Neurology.

[81]  J. Kaye,et al.  apoE isoforms and measures of anxiety in probable AD patients and Apoe−/− mice , 2005, Neurobiology of Aging.

[82]  Patrick Browne,et al.  Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. , 2005, Archives of neurology.

[83]  P. Yao,et al.  Preserved synaptic vesicle recycling in hippocampal neurons in a mouse Alzheimer's disease model. , 2005, Biochemical and biophysical research communications.

[84]  C. Kelche,et al.  Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior , 2005, Behavioural Brain Research.

[85]  D. Abrous,et al.  Adult Neurogenesis : From Precursors to Network and Physiology , 2005 .

[86]  J. Feldon,et al.  Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4 , 2005, Journal of the Neurological Sciences.

[87]  F. Oerlemans,et al.  Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit , 2005, Behavioural Brain Research.

[88]  Myriam Monczor,et al.  Diagnosis and Treatment of Alzheimers Disease , 2005 .

[89]  J. Stamler,et al.  Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study. , 2005, Atherosclerosis.

[90]  T. L. Briones,et al.  Dentate Gyrus Neurogenesis after Cerebral Ischemia and Behavioral Training , 2005, Biological research for nursing.

[91]  H. Tanila,et al.  Role of α-Synuclein in Presynaptic Dopamine Recruitment , 2004, The Journal of Neuroscience.

[92]  J. Davignon,et al.  Apolipoprotein E and atherosclerosis: beyond lipid effect. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[93]  T. Hara,et al.  Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus , 2004, Clinical and experimental pharmacology & physiology.

[94]  Lin Xie,et al.  Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Trojanowski,et al.  Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury , 2004 .

[96]  J. Trojanowski,et al.  Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury , 2004, Journal of neurochemistry.

[97]  K. Fassbender,et al.  High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs , 2004, Steroids.

[98]  Takashi Ito,et al.  [Taurine is a possible anti-atherosclerotic agent]. , 2004, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[99]  R. Curi,et al.  Effects of Fish Oil on the Central Nervous System: A New Potential Antidepressant? , 2004, Nutritional neuroscience.

[100]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[101]  Lin Xie,et al.  Increased hippocampal neurogenesis in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[102]  S. Scheff,et al.  Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies , 2003, Neurobiology of Aging.

[103]  Michael Dragunow,et al.  Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[104]  A. Kiliaan,et al.  Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats , 2003, Neurobiology of Learning and Memory.

[105]  G. Billman,et al.  Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. , 2003, Circulation.

[106]  R. Wurtman,et al.  Dietary cytidine (5′)-diphosphocholine supplementation protects against development of memory deficits in aging rats , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[107]  F. Pfrieger,et al.  Cholesterol homeostasis and function in neurons of the central nervous system , 2003, Cellular and Molecular Life Sciences CMLS.

[108]  H. Steinbusch,et al.  No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the β-cleaved C-terminal APP fragment , 2003, Neurobiology of Disease.

[109]  Takashi Takeuchi,et al.  Possible regulatory mechanism of DHA-induced anti-stress reaction in rats , 2003, Brain Research.

[110]  G. Kolovou,et al.  Apolipoprotein E Polymorphism and Atherosclerosis , 2003, Angiology.

[111]  F. Sacks,et al.  Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. , 2002, The American journal of medicine.

[112]  P. Luiten,et al.  Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion , 2002, Brain Research.

[113]  E. R. Kloet,et al.  Differential effect of corticosterone on spatial learning abilities in apolipoprotein E knockout and C57BL/6J mice , 2002, Brain Research.

[114]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[115]  D. Grobbee,et al.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.

[116]  P. Calder,et al.  Polyunsaturated fatty acids, inflammation, and immunity , 2001, Lipids.

[117]  T. Bayer,et al.  Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain DOI 10.1194/jlr.M200071-JLR200 , 2002, Journal of Lipid Research.

[118]  R. Morris,et al.  Spatial learning is unimpaired in mice containing a deletion of the alpha‐synuclein locus , 2002, The European journal of neuroscience.

[119]  R. Cuppini,et al.  Tocopherols enhance neurogenesis in dentate gyrus of adult rats. , 2002, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[120]  G. Arendash,et al.  Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment , 2002, Brain Research.

[121]  I. Carrié,et al.  Docosahexaenoic Acid-rich Phospholipid Supplementation: Effect on Behavior, Learning Ability, and Retinal Function in Control and n-3 Polyunsaturated Fatty Acid Deficient Old Mice , 2002, Nutritional neuroscience.

[122]  E. R. Kloet,et al.  Reversal of cognitive deficit of apolipoprotein E knockout mice after repeated exposure to a common environmental experience , 2001, Neuroscience.

[123]  A. Hafezi-Moghadam,et al.  ApoE Deficiency Compromises the Blood Brain Barrier Especially After Injury , 2001, Molecular medicine.

[124]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[125]  E. R. Kloet,et al.  Repeated exposure to rats has persistent genotype-dependent effects on learning and locomotor activity of apolipoprotein E knockout and C57Bl/6 mice , 2001, Behavioural Brain Research.

[126]  C. Specht,et al.  Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice , 2001, BMC Neuroscience.

[127]  Hideyuki Okano,et al.  Neurogenesis by Progenitor Cells in the Ischemic Adult Rat Hippocampus , 2001, Stroke.

[128]  D. Holtzman,et al.  Behavioral Phenotyping of GFAP-ApoE3 and -ApoE4 Transgenic Mice: ApoE4 Mice Show Profound Working Memory Impairments in the Absence of Alzheimer's-like Neuropathology , 2001, Experimental Neurology.

[129]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[130]  Yaakov Stern,et al.  Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.

[131]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[132]  D. Borchelt,et al.  Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. , 2001, Biomolecular engineering.

[133]  D van Ormondt,et al.  Cramér–Rao bounds: an evaluation tool for quantitation , 2001, NMR in biomedicine.

[134]  D. Laskowitz,et al.  Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response , 2001, Journal of Neuroimmunology.

[135]  L. Gibbons,et al.  Anxiety and Alzheimer's Disease , 2001, Journal of geriatric psychiatry and neurology.

[136]  C. Schweiger.  [Statins and the risk of dementia]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[137]  T. Arendt.  Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization , 2001, Neuroscience.

[138]  E. Preston,et al.  Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat , 2001, Experimental Brain Research.

[139]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[140]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[141]  S. Nishiyama,et al.  Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys , 2000, Brain Research.

[142]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[143]  Jacob Raber,et al.  Hypothalamic–Pituitary–Adrenal Dysfunction inApoe−/− Mice: Possible Role in Behavioral and Metabolic Alterations , 2000, The Journal of Neuroscience.

[144]  C. Jones,et al.  Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. , 2000, Journal of the American College of Cardiology.

[145]  L. Bridges,et al.  Regional distribution of tau, beta-amyloid and beta-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabelling study. , 1999, Neuroreport.

[146]  W. März,et al.  Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer’s disease-related lesions , 1999, Acta Neuropathologica.

[147]  W. Kukull,et al.  Anxiety of Alzheimer's disease: prevalence, and comorbidity. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[148]  Eric M. Reiman,et al.  Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes , 1999, Neurology.

[149]  A. L. Guerrero,et al.  Effects of vitamin E on ozone-induced memory deficits and lipid peroxidation in rats. , 1999, Neuroreport.

[150]  C. Walsh,et al.  Doublecortin Is a Microtubule-Associated Protein and Is Expressed Widely by Migrating Neurons , 1999, Neuron.

[151]  J. Poirier,et al.  Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice , 1999, Neuroscience.

[152]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[153]  S. Mcconnell,et al.  Doublecortin Is a Developmentally Regulated, Microtubule-Associated Protein Expressed in Migrating and Differentiating Neurons , 1999, Neuron.

[154]  J. Gilbert,et al.  Differential neurotrophic effects of apolipoprotein E in aged transgenic mice , 1999, Neuroscience Letters.

[155]  C. Hölscher.  Stress impairs performance in spatial water maze learning tasks , 1999, Behavioural Brain Research.

[156]  E. Gould,et al.  Learning enhances adult neurogenesis in the hippocampal formation , 1999, Nature Neuroscience.

[157]  K. Kogure,et al.  Biochemical and Molecular Characteristics of the Brain with Developing Cerebral Infarction , 1999, Cellular and molecular neurobiology.

[158]  T. Kameyama,et al.  Protective effects of idebenone and α‐tocopherol on β‐amyloid‐(1–42)‐induced learning and memory deficits in rats: implication of oxidative stress in β‐amyloid‐induced neurotoxicity in vivo , 1999 .

[159]  S. Scheff,et al.  Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. , 1998, Journal of neuropathology and experimental neurology.

[160]  B R Rosen,et al.  NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.

[161]  P. Bickford,et al.  Long-Term Dietary Strawberry, Spinach, or Vitamin E Supplementation Retards the Onset of Age-Related Neuronal Signal-Transduction and Cognitive Behavioral Deficits , 1998, The Journal of Neuroscience.

[162]  L. Mucke,et al.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[163]  D. Ryan,et al.  Apolipoprotein-E deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice , 1998, Brain Research.

[164]  J. Kleinman,et al.  Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains , 1997, Synapse.

[165]  B. Hyman,et al.  Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.

[166]  S. Oja,et al.  Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus , 1997, Neuroscience.

[167]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: animal studies. , 1997, The American journal of clinical nutrition.

[168]  L. Havekes,et al.  Severe learning deficits in apolipoprotein E-knockout mice in a water maze task , 1997, Brain Research.

[169]  H. Kaneto.  Learning/memory processes under stress conditions , 1997, Behavioural Brain Research.

[170]  S. DeKosky,et al.  Structural correlates of cognition in dementia: quantification and assessment of synapse change. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[171]  P. Milos,et al.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[172]  L. Mucke,et al.  Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[173]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[174]  H. Matsumoto,et al.  Effect of vitamin B complex on neurotransmission and neurite outgrowth. , 1996, General pharmacology.

[175]  D. Sparks,et al.  Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. , 1996, Dementia.

[176]  S. Oja,et al.  Taurine as osmoregulator and neuromodulator in the brain , 1996, Metabolic Brain Disease.

[177]  R N Kalaria,et al.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. , 1996, The American journal of pathology.

[178]  J. Poirier,et al.  Apolipoprotein E, synaptic plasticity and Alzheimer's disease. , 1995, Annals of medicine.

[179]  A. Smith,et al.  Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease , 1995, Neuroscience.

[180]  A. Roses,et al.  Neurodegeneration in the Central Nervous System of apoE-Deficient Mice , 1995, Experimental Neurology.

[181]  D. Michaelson,et al.  Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice , 1995, Neuroscience Letters.

[182]  B R Rosen,et al.  Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.

[183]  G. Arendash,et al.  Chronic antioxidant treatment improves the cognitive performance of aged rats , 1995, Brain Research.

[184]  J. D. Bruin,et al.  A behavioural analysis of rats with damage to the medial prefrontal cortex using the morris water maze: evidence for behavioural flexibility, but not for impaired spatial navigation , 1994, Brain Research.

[185]  J. Costentin,et al.  Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions , 1994, Behavioural Brain Research.

[186]  J. Gore,et al.  Intravascular susceptibility contrast mechanisms in tissues , 1994, Magnetic resonance in medicine.

[187]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[188]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[189]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[190]  T. Südhof,et al.  Synaptic Vesicle Traffic: Rush Hour in the Nerve Terminal , 1993, Journal of neurochemistry.

[191]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[192]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[193]  M. Plotkine,et al.  Concomitant increases in the extracellular concentrations of excitatory and inhibitory amino acids in the rat hippocampus during forebrain ischemia , 1992, Neuroscience Letters.

[194]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[195]  J W Belliveau,et al.  Functional cerebral imaging by susceptibility‐contrast NMR , 1990, Magnetic resonance in medicine.

[196]  J. Cleeman,et al.  The Cholesterol Facts , 2005 .

[197]  Richard J Martin,et al.  Assessment of Behavioral and Affective Symptoms in Alzheimer's Disease , 1990, Journal of geriatric psychiatry and neurology.

[198]  G Durand,et al.  The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. , 1989, The Journal of nutrition.

[199]  G. Cascino,et al.  Mossy fiber synaptic reorganization in the epileptic human temporal lobe , 1989, Annals of neurology.

[200]  David A. Drachman,et al.  Synaptic loss in Alzheimer's disease and other dementias , 1989, Neurology.

[201]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[202]  J. Jhamandas,et al.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. , 2013, Journal of psychiatry & neuroscience : JPN.

[203]  P. Dederen,et al.  Cholesterol and synaptic compensatory mechanisms in Alzheimer's disease mice brain during aging. , 2012, Journal of Alzheimer's disease : JAD.

[204]  Cornelis J Stam,et al.  Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. , 2012, Journal of Alzheimer's disease : JAD.

[205]  M. Ergelen,et al.  Increased mean platelet volume associated with extent of slow coronary flow. , 2012, Cardiology journal.

[206]  D. Michaelson,et al.  The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. , 2012, Journal of Alzheimer's disease : JAD.

[207]  P. Scheltens,et al.  Can nutrients prevent or delay onset of Alzheimer's disease? , 2010, Journal of Alzheimer's disease : JAD.

[208]  M. Boada,et al.  A diet enriched in polyphenols and polyunsaturated fatty acids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain. , 2009, Journal of Alzheimer's disease : JAD.

[209]  P. Passmore,et al.  Statins for the prevention of dementia. , 2009, The Cochrane database of systematic reviews.

[210]  J. O’Keefe,et al.  Fish oil in primary and secondary cardiovascular prevention. , 2008, The Ochsner journal.

[211]  Eric Tardif,et al.  Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. , 2008, Journal of Alzheimer's disease : JAD.

[212]  Victoria J. Bourne,et al.  n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. , 2008, The American journal of clinical nutrition.

[213]  U. Das.  Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why? , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[214]  H. Tanila,et al.  Role of alpha-synuclein in synaptic glutamate release. , 2007, Neurobiology of disease.

[215]  P. Zandi,et al.  Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. , 2005, Neurology.

[216]  V. Henderson,et al.  Diagnosis and Treatment of Alzheimer's Disease , 2005 .

[217]  D. Borchelt,et al.  Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. , 2004, Human molecular genetics.

[218]  J. Joven,et al.  Circulating blood cells modulate the atherosclerotic process in apolipoprotein E-deficient mice. , 2004, Metabolism: clinical and experimental.

[219]  L. Xie,et al.  Alzheimer病トランスジェニック(PDGF‐APPSw,Ind)マウス , 2004 .

[220]  H. Tanila,et al.  Role of alpha-synuclein in presynaptic dopamine recruitment. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[221]  S. Onen,et al.  Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease [correction of disase]. , 2003, Clinical hemorheology and microcirculation.

[222]  S. Murakami,et al.  Taurine reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. , 2000, Advances in experimental medicine and biology.

[223]  T. Kameyama,et al.  Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. , 1999, The European journal of neuroscience.

[224]  S N Thibodeau,et al.  Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. , 1999, Neurology.

[225]  J. D. Smith,et al.  Mouse models of atherosclerosis. , 1998, Laboratory animal science.

[226]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.

[227]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[228]  K. Weisgraber.  Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[229]  V. Claassen.  Neglected factors in pharmacology and neuroscience research , 1994 .

[230]  G. Pascal,et al.  Essentiality of omega 3 fatty acids for brain structure and function. , 1991, World review of nutrition and dietetics.

[231]  G. Pascal,et al.  Essentiality of ω3 Fatty Acids for Brain Structure and Function1 , 1991 .

[232]  D. Reuter,et al.  Effect of vitamin B , 1980 .